“Fourth-quarter deal volume was strong, thanks to a busy December,” said Lisa E. Phillips, editor of HealthCareMandA.com. “Heading into 2020, we expect another strong year in the healthcare market—at least until the November elections.”

NORWALK, Conn. (PRWEB)
January 19, 2020

Health care merger and acquisition activity essentially held steady in the fourth quarter of 2019, compared with the third quarter. The number of deals announced fell 3%, to 442, compared with the previous quarter’s 456 transactions, and was 12% lower than the 504 deals announced in the same quarter in 2018. Combined spending in the fourth quarter totaled $63.4 billion, up 22% compared with the previous quarter’s $52.1 billion. It was 47% greater than the approximately $43.1 billion reported in the same quarter in 2018, according to HealthCareMandA.com

Healthcare services transactions made up 69% of the fourth quarter’s deal volume, similar to the previous four quarters. The Long-Term Care sector once again ranked the busiest, with 110 deals and a 25% share of the quarter’s transaction total. Year-over-year, two of the services sectors posted impressive gains—Home Health & Hospice (+40%) and Managed Care (+200%). Combined spending on the services side accounted for only 38% of the quarter’s total, approximately $24 billion, based on disclosed prices.

Healthcare technology deals accounted for 31% of the fourth quarter’s deal volume. The eHealth sector was the busiest, posting 63 deals to make up 14% of the quarter’s total. Year-over-year, eHealth was the only technology sector to post an increase in deal volume, up 9% compared with the fourth quarter of 2018. Combined spending among the technology sectors was $39.4 billion.

“Fourth-quarter deal volume was strong, thanks to a busy December,” said Lisa E. Phillips, editor of HealthCareMandA.com. “Heading into 2020, we expect another strong year in the healthcare market—at least until the November elections.”

As healthcare mergers and acquisitions go, 2019 was another good year. Preliminary data show a total of 1,774 deals announced, the second-highest on record. The total is just 7% lower than 2018’s record of 1,908 transactions.

Last year’s spending total is another story, and one for the record books. Preliminary data show $401.7 billion went to finance healthcare deals in 2019, and that’s just disclosed spending. Not only is that a record, it beat the previous record ($333.3 billion, set in 2018) by 21%.

All quarterly results are published in The Health Care M&A, which is part of the HealthCareMandA.com investment research source. Sector-specific research and analysis can be found at Levin Associates 2019 Sector Reports. For information, or to order the report, call 800-248-1668. Irving Levin Associates is celebrating more than 70 years of delivering exclusive M&A intelligence to its sophisticated audience of seniors housing and healthcare investors. The company was established in 1948 and has headquarters in Norwalk, Connecticut.

Share article on social media or email:

“This sector has seen years of growth as PE firms have piled in to build national and regional platforms around addiction treatment and autism programs. It’s not surprising to see contraction after years of growth,” said Lisa Phillips, editor of The Health Care M&A Report, which publishes the data.

NORWALK, Conn. (PRWEB)
January 19, 2020

Activity in the behavioral health care M&A market slowed in the fourth quarter of 2019, down 21% with 15 publicly announced transactions, compared with 19 transactions in the third quarter, according to data from HealthCareMandA.com. The decline in deal volume was even more dramatic compared with the fourth quarter of 2018. Deal volume in Q4:19 was down by 46% versus the 28 deals announced a year earlier. Only one transaction disclosed a price in the quarter, for $415 million.

“This sector has seen years of growth as private equity firms have piled in to build national and regional platforms around addiction treatment and autism programs and services. It’s not surprising to see more contraction after several years of growth,” said Lisa E. Phillips, editor of The Health Care M&A Report, which publishes the data. “Autism is still the hottest commodity in the sector, but investor interest in substance abuse programs and inpatient psychiatric facilities has waned a bit.”

The sole deal to report a price was announced by Thomas H. Lee Partners. The private equity firm paid $415 million to acquire Centria Healthcare from Martis Capital and Lorient Capital. Centria is the largest provider in Michigan and operates in Arizona, California, Indiana, Massachusetts, Minnesota, New Jersey, New Mexico, Oregon, Texas and Washington. It also provides pediatric nursing and catastrophic injury care.

Discovery Behavioral Health, a portfolio company of Webster Equity Partners, was the most active acquirer in the quarter, announcing three transactions targeting companies specializing in drug and alcohol treatment programs in California (2) and Maryland (1).

All quarterly results are published in The Health Care M&A, which is part of the HealthCareMandA.com investment research source. Sector-specific research and analysis can be found in The Behavioral Health Care Acquisition Report 2019 . For information, or to order the report, call 800-248-1668. Irving Levin Associates is celebrating more than 70 years of delivering exclusive M&A intelligence to its sophisticated audience of seniors housing and healthcare investors. The company was established in 1948 and has headquarters in Norwalk, Connecticut.

Share article on social media or email:

Dr. Nickelice Brand, Ocala, FL Dentist, Lectures on How to Improve Dental Implant Treatment

With over 25 years of experience as a dentist in Ocala, FL, Dr. Brand has learned how to connect with his staff and his patients in order to improve patients’ overall experience.

Ocala, FL (PRWEB)
January 15, 2020

Dr. Nickelice Brand and Hiossen® Implant welcome dentists and dental implant specialists to a one-day event at the Hiossen corporate office in Orlando, FL on January 16, 2020. A dentist in Ocala, FL who places over 1,000 dental implants each year, Dr. Brand will lend his expertise to fellow dentists and implant specialists, as well as their staff, on how to best serve patients in need of advanced dental implant procedures. The event will be held at 6 p.m. at the Hiossen office located at 200 E Robinson Street, Suite 210 in Orlando, FL.

At the event, Dr. Brand will train dental professionals and their staffs how to improve patient education on their dental implant options. The goal is to help dentists and implant specialists train their staff to effectively communicate with dental implant patients and schedule them for the best possible treatment for their case.

Dr. Brand is passionate about helping improve dental care in his community as well as across the country. With over 25 years of experience as a dentist in Ocala, FL, Dr. Brand has learned how to connect with his staff and his patients in order to improve patients’ overall experience. He values sharing that knowledge with fellow dentists and implant specialists to help them improve care at their own practices as well.

At his practice, Dental Implants of Ocala, Dr. Brand offers some of the most advanced dental implant procedures available in the industry. Utilizing the latest in technology, Dr. Brand can replace a single missing tooth, multiple missing teeth, or an entire arch of missing teeth with permanent, stable dental implants. In addition to traditional dental implants, Dr. Brand also offers ceramic dental implants for patients who would prefer a metal-free tooth replacement. For those needing full mouth dental implants, Dr. Brand can provide full-arch restoration in just one day using as few as four dental implants.

Those looking to replace missing teeth from Orlando to Ocala, FL are invited to connect with Dr. Brand for a dental implant consultation. To learn more about Dr. Brand, Dental Implants of Ocala, or the Hiossen event on January 16, visit http://www.dentalimplantsofocala.com or call 352-653-2500.

About the Dentist

Dental Implants of Ocala offers specialized and all-inclusive dental implant treatment to patients of Marion County, including Ocala, FL and beyond. Dr. Nickelice Brand, the practice’s leading implant dentist, has over 25 years of experience and focuses solely on providing innovative implant solutions for his patients. Placing over 1,000 implants a year, Dr. Brand has retained a 98 percent implant success rate and an even higher level of patient satisfaction. The team at Dental Implants of Ocala remains up to date on implant dentistry’s most innovative and unique technologies, including bone morphogenetic protein and CeraRoot ceramic dental implants, to ensure the highest standard of care and most predictable treatment outcomes. To learn more about Dental Implants of Ocala and their innovative implant care, visit http://www.dentalimplantsofocala.com or call 352-653-2500.

Share article on social media or email:

The education agenda will address the most pressing industry concerns and interests, including robotics, ATMPs, and automated visual inspections.

BETHESDA, Md. (PRWEB)
January 16, 2020

The International Society for Pharmaceutical Engineering (ISPE) announced its 2020 ISPE Aseptic Conference, taking place 2–3 March 2020 in North Bethesda, Maryland. Now in its 29th year, this signature event has established itself as the pharmaceutical industry’s leading source on advancing aseptic and barrier operations and providing invaluable opportunities for peer-to-peer learning through interactions with industry and regulatory leaders.

“While many conferences just discuss the theoretical aspects of aseptic, barrier, and containment, the ISPE Aseptic Conference provides attendees with insights from owner experiences and lessons learned through in-depth presentations, panel discussions, and group breakout sessions,” said Jörg Zimmermann, 2020 ISPE Aseptic Conference Chair, Vice President Vetter Development Service, External Affairs, Vetter Pharma-Fertigung GmbH & Co KG. “The education agenda will address the most pressing industry concerns and interests, including robotics, ATMPs, and automated visual inspections.”

The 2020 program will focus on providing flexible and reliable solutions for the implementation and management of the latest in aseptic, barrier, containment, and aseptic best-practice technologies.

Featured speakers include:

Richard Friedman, Deputy Director, Science and Regulatory Policy, FDA/CDER

• 
  Robert Sausville, Director, Div. Case Management, FDA/CBER
• David Doleski, Compliance Head for Biologics Quality Operations, Sanofi
• Christophe Riedel, CEO, Claranor SA
• Eugen Goidenko, Executive Vice President, Bausch Advanced Technologies Inc.
• Dawn Watson, Director, Microbial Control & Sterile Site Support Sterile & Validation COE, Merck & Co., Inc.
• Zhihao Qiu, PhD, Director (Acting), Office of Pharmaceutical Manufacturing Assessment, FDA/CDER/OPQ/OPF
• Brooke Higgins, Senior Policy Advisor, Office of Manufacturing Quality, Division of Drug Quality, FDA/CDER/OC/OMQ
• And more

To explore the agenda and to register, please visit ISPE.org/Aseptic20.

About ISPE

The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,500 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland USA, and its operations center in Tampa, Florida USA. Visit ISPE.org for more information.

For more information, contact:

Amy Henry

Marketing Communications Manager

International Society for Pharmaceutical Engineering (ISPE)

Tel: +1-813-960-2105

Email: ahenry@ispe.org

ISPE.org

Share article on social media or email:

BCEN’s “Support Your Emergency Nurses to Board Certified Success: A Step-by-Step Guide”

“Board certified emergency nurses bring unmatched levels of motivation and knowledge to the table. BCEN’s new white paper details specific ways leaders and organizations can cultivate emergency nursing excellence.”

OAK BROOK, Ill. (PRWEB)
January 16, 2020

The Board of Certification for Emergency Nursing (BCEN), the benchmark for board certification across the emergency nursing spectrum, today released the white paper “Support Your Emergency Nurses to Board Certified Success: A Step-by-Step Guide” for nurse leaders, administrators and healthcare organizations interested in helping their registered nurses (RNs) earn their specialty board certifications. BCEN offers five national board certifications for emergency, trauma and transport RNs.

“Board certified emergency nurses bring unmatched levels of motivation and knowledge to the table,” said BCEN Executive Director Janie Schumaker, MBA, BSN, RN, CEN, CENP, CPHQ, FABC. “BCEN’s new white paper details specific ways leaders and organizations can generate an environment that cultivates nursing excellence by supporting their nurses to achieve and maintain board certification.”

The new step-by-step guide describes tried-and-true and creative ways to encourage, support and reward board certification. Throughout the guide, nurse and physician leaders from institutions of all sizes share how and why board certification thrives in their emergency departments, trauma centers and organizations, leading to better quality of care and nurses with exceptional specialty knowledge and expertise, confidence, engagement and satisfaction.

Featured in the white paper are:

• Four key steps to create and sustain a culture of certification
• Idea Center with 50 ways to support certification
• How to overcome common objections
• Secrets of success from hospital leaders committed to certification

“Support Your Emergency Nurses to Board Certified Success,” which is a follow-on to BCEN’s first two white papers, also connects readers with a variety of online and downloadable resources for nurses, nurse leaders and organizations such as exam content outlines, full-length practice exams, test anxiety tips, a nurse recognition toolkit and BCEN’s volume discount certification voucher program.

To download the free white paper, visit: https://bcen.org/white-paper-step-by-step-guide/.

About BCEN

Founded in 1980, the independent, not-for-profit Board of Certification for Emergency Nursing (BCEN®) is celebrating 40 years of robust certification programs fostering empowered nurses across the emergency spectrum who contribute noticeably to patient care, safety and outcomes. Over 54,000 BCEN board certifications are currently held by registered nurses (RNs) who specialize in emergency, flight, critical care ground transport, pediatric emergency and trauma nursing. BCEN offers the Certified Emergency Nurse (CEN®), Certified Flight Registered Nurse (CFRN®), Certified Pediatric Emergency Nurse (CPEN®), Certified Transport Registered Nurse (CTRN®) and Trauma Certified Registered Nurse (TCRN®) certifications. The CEN, CFRN, CPEN, and TCRN certification programs are accredited by the Accreditation Board for Specialty Nursing Certification (ABSNC). Learn more at bcen.org. Follow BCEN on Facebook, LinkedIn and Instagram.

Share article on social media or email:

All kinds of people are now taking advantage of gestational surrogacy to grow their families.

Families turn to surrogacy for a number of reasons and it’s crucial all involved have the information they need to make an informed decision.

LOS ANGELES (PRWEB)
January 18, 2020

A December 24 article in The Salt Lake Tribune reports on the growing acceptance of surrogacy and the safeguards that are increasingly protecting everyone involved in the process of bringing a new child into the world. Naturally, the parental journey looks different for every family, and the article discusses the importance of careful consideration before entering into the surrogacy process, both for intended parents and potential gestational surrogates. As the article mentions, families turn to surrogacy for a number of reasons and it’s crucial all involved have the information they need to make an informed decision. Global Surrogacy Services says that one of its main goals is to provide intended parents and surrogates all of the necessary information needed to make a truly informed decision.

Global Surrogacy Services states that its team of highly experienced medical and legal professionals covers an extremely wide range of tasks. These include selecting the very best fertility specialists and obstetricians as well as finding the knowledgeable legal professions needed to navigate each aspect of the surrogacy journey appropriately. The firm adds that one of its most important offerings is its highly detailed screening process for women who are interested in becoming surrogates, which includes both physical and psychological screening. To become a surrogate is a life-changing decision and requires a special kind of woman who truly wants to help a family know the joy of parenthood and who is also physically and mentally ready to do so, says the agency.

Intended parents, as well as potential surrogates, will be interested in the basic requirements for a woman to become a surrogate with Global Surrogacy Services. Women should be between the ages of 21 to 38, must have previously given birth without complications, and must currently have a child at home. Naturally, it is also a requirement that the gestational surrogate is a non-smoker with a smoke-free household, has no history of substance abuse and must live in a generally safe and healthy environment. Of course, having a child under any circumstances is no small task and surrogates are compensated for their effort and time, says the agency. It notes that former-surrogates often take advantage of their windfall to make significant improvements in their lives such as going back to school or buying a long-needed family car.

As for intended parents, Global Surrogacy Services says that, while some intended parents try to go it alone, the medical and legal complexities involved with arranging a gestational surrogacy makes that not only a herculean task but one fraught with potential risks. With any task this complicated, it is best to allow professionals who understand the details handling the process. The agency notes that it has helped couples and individuals of all walks of life and orientations enjoy a smooth and fulfilling parental journey.

For further information, call Global Surrogacy Services at (800) 355-2009 or visit its website at https://www.globalsurrogacyservices.com/.

Share article on social media or email:

It is clear that AI is transforming our industry in a radical way. By leveraging deep learning and artificial intelligence technologies USARAD is well positioned to continue its global leading position.

FT. LAUDERDALE, Fla. (PRWEB)
January 16, 2020

USARAD Holdings Inc., the leading US Joint Commission Accredited teleradiology and telemedicine company backed by Siemens Healthineers and several healthcare VC firms announces successful collaboration with its partner, Siemens Healthineers. The companies collaborated on the lung nodule detection part of the AI-Rad Companion Chest CT software which assists radiologists in detection of pulmonary nodules. This software was awarded the CE mark in Europe as well as 510k FDA approval and can start to be marketed as a medical product effective immediately.

Dr. Matthias Mitschke coordinated the project and worked together with Dr. Anna Jerebko and her team who oversaw the development of the lung nodule detection software. Anna and Matthias championed this collaboration which involved multiple steps. According to Siemens specifications, USARAD together with MDW developed specialized AI annotation software and radiology workflow for the project. USARAD then leveraged MDW technology to assist in obtaining over 10,000 deidentified computed tomography cases, radiology reports and annotations from its data partners. The image data as well as the clinical reports were carefully anonymized in compliance with HIPAA. Unique heterogeneous acquired CT data was obtained from over 100 imaging centers in multiple states throughout USA. Siemens Healthineers, USARAD and MDW then collaborated to oversee numerous radiologists who provided annotations in multiple phases which included providing input for an FDA submission.

Anna stated, “We are pleased to work together with USARAD on data collection for AI development. It is very important to ‘stress test’ medical imaging and computer aided detection algorithms on as much data as possible with a large variety of different acquisition protocols, scanner models and patient populations to ensure stable performance thus assessing its generalizability and for use in medical practice. The massive amount of chest CT scans were read and annotated by multiple experienced radiologists. In this manner, the performance of the AI algorithm could be benchmarked against the opinions of experts. It is a very common pitfall in AI development when an algorithm is trained and tested on a limited amount of data acquired from a single site possibly with scanner(s) from a single vendor and interpreted by only a few radiologists. This type of evaluation can lead to conclusions on algorithm results that are too optimistic and can manifest in a suboptimal performance in clinical practice. Stress-testing the AI algorithms for chest CT on a massive amount on clinical data has shown a significant improvement compared to existing standard CAD algorithms.”

Previously USARAD and Siemens Healthineers have announced a world-wide distribution partnership with USARAD services to be offered via a global cloud-based sharing and collaboration platform as part of the teamplay digital health platform. This partnership is currently being expanded to include AI collaboration and the integration with teamplay environment is ongoing. USARAD is excited to deploy this solution and other algorithms in its daily practice upon FDA approval. At the same time, USARAD plans to deploy multiple additional algorithms which are not yet FDA approved in research setting using the teamplay environment.

It is anticipated that algorithm’s outputs will become part of reporting to facilitate radiologists’ workflow with an overall anticipated significant improvement of speed and efficiency. USARAD is also excited to continue collaborating with Siemens Healthineers on multiple new AI projects.

“It is clear that AI is transforming our industry in a radical way. By leveraging deep learning and artificial intelligence technologies USARAD is well positioned to continue its global leading position and will accelerate its quest to affordably bring high quality healthcare around the world,” explained Michael Yuz, M.D. MBA, CEO and founder of USARAD Holdings Inc.“ Dr Yuz is considered to be both the leading expert physician and serial entrepreneur in the field of Artificial Intelligence. He has helped develop algorithms as well as has invested into health-related AI platforms since 2005. He added, “Our involvement with AI is quiet strategic, because not only are we able to provide assistance in developing these AI algorithms, but, when they gain required approval status, we are also able to immediately integrate these algorithms into the production, workflows and day-to-day practice.”

About USARAD Holding Inc. including SecondOpinions.com®

USARAD Holdings, Inc. is a global telemedicine company consisting of two operating divisions – USARAD and SecondOpinions.com®. USARAD is a radiology services provider offering interpretations of a full range of sub-specialty and general radiology patient studies. With an existing advanced technology network connecting medical facilities to board-certified radiologists and support staff, USARAD offers radiology services in all 50 states as well as more than 15 countries. Via its unique Radiology-On-Demand® platform, USARAD is committed to providing timely and responsive image review 24/7. SecondOpinions.com® is a medical consultation and second opinions leader providing health care customers, physicians and consumers with expert opinions from all medical specialties and sub-specialties. For more information please visit http://usarad.com or email Elli Yuz at elli@secondopinions.com

About MDW.io

Medical diagnostic web (MDW.io) is first of its kind decentralized autonomous organization operating Blockchain based platform which utilizes smart-contract to facilitate complex B2B and consumer transactions between various stakeholders in radiology field. MDW.io designed to facilitate remote medical diagnostic consultations including radiologic and multispecialty second opinions, peer reviews, primary and preliminary teleradiology interpretations as well as synchronous and asynchronous telemedicine visits. MDW puts patients in forefront of their diagnostic health records by allowing patients and their diagnostic providers to upload findings in a secure, anonymized manner to be further evaluated by the community. For more information please visit http://mdw.io or email Michael Averbach at mja@mdw.io.

Share article on social media or email:

University Health System is leading the region in developing a mobile wayfinding platform to improve overall access to healthcare for patients.

“Digital transformation in healthcare has arrived, and University Health System is leading the region in developing a mobile platform that will improve overall access to healthcare for our patients,” Selene Mejia, University Health System digital marketing manager.

SAN ANTONIO (PRWEB)
January 17, 2020

University Health System has selected Atlanta-based Gozio Health to develop the system’s interactive mobile wayfinding platform. The hospital-branded mobile wayfinding and patient engagement platform will provide intuitive, turn-by-turn indoor navigation at University Hospital and its parking garage, with additional access to 28 satellite clinics and urgent care centers. The wayfinding platform will cover more than 3 million square feet of navigation.

The interactive digital platform will also give patients and visitors immediate access to physician directories, electronic medical records, and locations of cafes, pharmacies and the closest restrooms on their smartphones.

“Digital transformation in healthcare has arrived, and University Health System is leading the region in developing a mobile platform that will improve overall access to healthcare for our patients,” said Selene Mejia, University Health System digital marketing manager. “Not only will our mobile wayfinding platform direct patients to their exact appointment location, it will make it very convenient for patients to schedule an appointment or view health records through the app.”

Statistics based on adult, university and children’s hospital systems show that once a Gozio mobile wayfinding app is installed to navigate to a destination within the hospital system, more than 85 percent of users return to the app to schedule appointments, access medical records, search physician directories and view hospital amenities.

“For hospitals to remain competitive, they must provide patients with a digital platform that features location-based services, appointment scheduling, and access to their patient portal from their smartphone,” said Joshua Titus, CEO and Founder Gozio Health. “We welcome the opportunity to work with University Health System and support their commitment to innovation in patient experience.”

Gozio Health

Gozio Health transforms indoor navigation and significantly improves patient experience with an experiential wayfinding platform specifically designed for hospitals and healthcare systems. Gozio’s platform optimizes the patient journey beyond wayfinding with API integrations of electronic health records, urgent care and emergency department wait times, Save My Spot scheduling for urgent care, virtual visits, and more. For more information, visit http://www.goziohealth.com or find Gozio Health on Twitter and LinkedIn.

University Health System

University Health System is a nationally recognized teaching hospital and comprehensive network of outpatient healthcare centers throughout San Antonio, Texas, and is the region’s only civilian Level 1 trauma center. University Health System is owned by the people of Bexar County and partnered with UT Health San Antonio, making it South Texas’ only academic medical center.

Share article on social media or email:

We agree with Dr. Pagnano’s comments on this study. While patients make the ultimate decision on whether to proceed with total knee replacement, the surgeon should advise patients on their rehab potential and overall health, says Dr. Gay

FREMONT, Calif. (PRWEB)
January 17, 2020

In a recent article in USA TODAY, the results of this study, published in The Journal of Bone and Joint Surgery, were detailed. The research suggests that for far too many patients, having a knee replacement procedure is done either too late or too soon. The team at Northwestern University’s Feinberg School of Medicine in Chicago found that 90% of patients who could benefit from the procedure waited too long to have it. Alternatively, about 25% of patients who don’t need the surgery are having it prematurely when the benefit is minimal, and they run the risk of complications. Patients with osteoarthritis in the knee should time the surgery to ensure maximum benefits if they are eligible for knee replacement.

In the article, Dr. Mark Pagnano, who is unaffiliated with the study and a professor and chairman of the Department of Orthopedic Surgery at Mayo Clinic, told USA TODAY that despite advancements in the procedure, some people that should have knee replacement surgery hold on to antiquated notions of its risks and outcomes and put off having it done. However, he also emphasized that there may be serious issues in getting the surgery too early. “There’s a sense among some people that a knee replacement will magically cure any problem that’s related to the knee. Particularly for younger, active patients, they will continue to push for a permanent fix to a problem when perhaps a surgical option is still not in their best interest,” Dr. Pagnan explained.

“We agree with Dr. Pagnano’s comments on this study. While patients make the ultimate decision on whether to proceed with total knee replacement, the surgeon should advise patients on their rehab potential and overall health,” says Dr. Gay.

“At our practice, we spend a great deal of time counseling patients so they can make the most informed decision possible,” explains Dr. Reynolds

At Silicon Valley Orthopaedics, Dr. Nic Gay and Dr. Kerisimasi Reynolds fully understand the implications of having joint replacement surgery and typically only recommend joint replacement when conservative or joint preservation treatments are not viable options for eliminating pain and restoring function. They use indicators such as pain level, joint function, age and x-ray assessment to determine if or when knee replacement is necessary. Dr. Gay and Dr. Reynolds have intimate knowledge of knee anatomy and associated illnesses, providing patients with access to the highest standard of care.

More about Silicon Valley Orthopaedics (SVO):

Silicon Valley Orthopaedics (SVO) is located at 39180 Farwell Dr., Suite 110, in Fremont, CA. Dr. Nic Gay and Dr. Kerisimasi Reynolds help patients across San Jose and the Silicon Valley area reach their musculoskeletal health goals at this state-of-the-art practice, utilizing innovative, evidence-based surgical and non-surgical techniques. They provide an accurate diagnosis and appropriate treatment plans to address joint pain so that patients achieve optimum results.

If you are concerned about joint health and would like an expert consultation with a specialist orthopedic surgeon, contact Silicon Valley Orthopaedics (SVO) today. Call (650) 379-4616 to learn more or visit http://www.siliconvalleyortho.com.

Share article on social media or email: